Evidence of high mortality in long term survivors of childhood medulloblastoma

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Neuro-Oncology

• Publication date

  2015-01-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11060-014-1712-yPMID 25557108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytogenetic prognostication within medulloblastoma subgroups.

  2014cited by this paper
• Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.

  2013cited by this paper
• Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.

  2013influential reference
• Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average‐risk medulloblastoma: COG A9961

  2013cited by this paper
• Outcome and prognostic factors of radiation therapy for medulloblastoma.

  2011cited by this paper
• Recurrence in childhood medulloblastoma

  2011cited by this paper
• Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations.

  2010cited by this paper
• Universal Poor Survival in Children With Medulloblastoma Harboring Somatic TP53 Mutations

  2010cited by this paper
• From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980–2000)

  2009cited by this paper
• Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.

  2009cited by this paper
• Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.

  2009cited by this paper
• Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.

  2009cited by this paper
• Survival and late mortality in long-term survivors of pediatric CNS tumors.

  2007cited by this paper
• Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer

  2006cited by this paper
• Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

  2006cited by this paper
• New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

  2006cited by this paper
• Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

  2006cited by this paper
• An analysis of SEER data of increasing risk of secondary malignant neoplasms among long‐term survivors of childhood brain tumors

  2006cited by this paper
• Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.

  2005cited by this paper
• Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

  2000cited by this paper
• Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group.

  1996cited by this paper
• Patterns of failure in surgical therapy of medulloblastomas.

  1995cited by this paper
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

  1988cited by this paper
• Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival

  1988cited by this paper
• Cohort Analysis in Epidemiology

  1985cited by this paper
• A Celebration of Statistics

  1985cited by this paper
• Medulloblastoma: clinical presentation and management. Experience at the hospital for sick children, toronto, 1950-1980.

  1983cited by this paper
• Epidemiologic Analysis with a Programmable Calculator

  1982cited by this paper

• Late Mortality Among Survivors of Childhood Cancer in Canada: A Retrospective Cohort Study

  2025cites this paper
• Long-term epidemiological trends in (primary) pediatric central nervous system tumors: a 25-year cohort analysis in Western Mexico

  2025cites this paper
• Late Effects in Survivors of Pediatric Medulloblastoma: A Comprehensive Review

  2025cites this paper
• Advancing medulloblastoma therapy: strategies and survival insights

  2025cites this paper
• Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review

  2024cites this paper
• Multidisciplinary monitoring in pediatric patients with medulloblastoma by primary care physician

  2024cites this paper
• Beijing Children’s Hospital guidelines on the design and conduction of the first standardized database for medulloblastoma

  2023cites this paper
• Impact of immobilisation and image guidance protocol on planning target volume margins for supine craniospinal irradiation

  2022cites this paper
• Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients

  2022cites this paper
• Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

  2021cites this paper
• Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood

  2020cites this paper
• A Monte Carlo-Based Analytic Model of Neutron Dose Equivalent for a Mevion Gantry-Mounted Passively Scattered Proton System for Craniospinal Irradiation.

  2020cites this paper
• Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches

  2020cites this paper
• Epidemiological characteristics and survival outcomes of children with medulloblastoma treated at the National Cancer Institute (INCA) in Rio de Janeiro, Brazil

  2020cites this paper
• Medulloblastoma - Introduction.

  2020cites this paper
• [Glioblastomas in patients with medulloblastomas after combined treatment].

  2020cites this paper
• Targeting the medulloblastoma: a molecular-based approach

  2020cites this paper
• Exosomal miR-130b-3p targets SIK1 to inhibit medulloblastoma tumorigenesis

  2020cites this paper
• Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival

  2019cites this paper
• Radiotherapy Advances in Paediatric Medulloblastoma Treatment.

  2019cites this paper
• Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling

  2019cites this paper
• Endocrine Late Effects of Cancer Treatments

  2019cites this paper
• Childhood medulloblastoma—a single institution’s historical perspective on survival and functional morbidity

  2019cites this paper
• Signs of radiation-induced accelerated ageing in survivors of childhood brain tumors : the incidence of cerebrovascular disease, neurocognitive impairment, secondary neoplasms, and low bone mineral density after 18 years of follow-up

  2019cites this paper
• Disseminated High-grade Glioma in a Long-term Survivor of Medulloblastoma: Implications and Management of Radiation-induced Malignancies

  2018cites this paper
• Ubiquitination by HUWE1 in tumorigenesis and beyond

  2018cites this paper
• Pediatric and Adult Medulloblastoma: Experience About 96 Cases

  2018cites this paper
• Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas

  2018cites this paper
• Long-Term Outcomes Among Survivors of Childhood Central Nervous System Malignancies: Late Mortality, Subsequent Neoplasms, Endocrine and Neurologic Morbidity

  2018cites this paper
• Meta‐analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma

  2018cites this paper
• Meduloblastoma: de la clasificación histológica a la molecular

  2018cites this paper
• Epidemiology of Pediatric Central Nervous System Tumors

  2018cites this paper
• Endocrine Sequelae of Central Nervous System Irradiation

  2018cites this paper
• Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry

  2018cites this paper
• Childhood Medulloblastoma Revisited

  2018cites this paper
• Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic Review.

  2018cites this paper
• Monte Carlo simulation of secondary neutron dose for scanning proton therapy using FLUKA

  2017cites this paper
• Pediatric Emergency Medicine: Chief Complaints and Differential Diagnosis

  2017cites this paper
• DIAGNOSIS OF ENDOCRINE DISEASE: Endocrine late-effects of childhood cancer and its treatments.

  2017cites this paper
• Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication

  2017cites this paper
• Measured Neutron Spectra and Dose Equivalents From a Mevion Single-Room, Passively Scattered Proton System Used for Craniospinal Irradiation.

  2016cites this paper
• Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns

  2016cites this paper
• Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm

  2016cites this paper
• Caracterización clínica de pacientes pediátricos con tumores cerebrales primarios en un hospital de Bogotá entre 2007-2014

  2016cites this paper
• Reprogramming Medulloblastoma-Propagating Cells by a Combined Antagonism of Sonic Hedgehog and CXCR4.

  2016cites this paper
• The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells

  2015cites this paper
• Pediatric Brain Tumors: Imaging of Late Effects in Pediatric Brain Tumor Survivors

  2015cites this paper
• World Journal of Clinical Oncology

  year unknowncites this paper